András Vida
Impact in
- Hepatology top 10%
- Liver Disease and Transplantation
- Geriatrics and Gerontology top 10%
Papers in
-
- Gut microbiota and health 3
- Oncology 5
- PARP inhibition in cancer therapy 4
- HER2/EGFR in Cancer Research 1
- Co-authors
- Péter Bai (11 shared papers)Edit Mikó (4 shared papers)Judit Márton (4 shared papers)Katalin Mikecz (3 shared papers)Tibor T. Glant (3 shared papers)Tündé Kovàcs (3 shared papers)Borbála Kiss (2 shared papers)Zoltán Szekanecz (2 shared papers)
- Journals
- PLoS ONE (3 papers)Journal of Pharmaceutical and Biomedical Analysis (1 paper)Inflammation Research (1 paper)Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (1 paper)British Journal of Pharmacology (1 paper)
- Partner nations
- HungaryUnited StatesNetherlands
In The Last Decade
András Vida
18 papers receiving 619 citations
Peers
Comparison fields: 5 of 79
- Hepatology 61
- Geriatrics and Gerontology 24
- Oncology 177
- Immunology 121
- Physiology 22
Countries citing papers authored by András Vida
This map shows the geographic impact of András Vida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by András Vida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites András Vida more than expected).
Fields of papers citing papers by András Vida
This network shows the impact of papers produced by András Vida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by András Vida. The network helps show where András Vida may publish in the future.
Co-authors
The 25 scholars most cited alongside András Vida, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 148 | |
| 2 | 2011 | 87 | |
| 3 | 2016 | 54 | |
| 4 | 2014 | 48 | |
| 5 | 2018 | 45 | |
| 6 | 2017 | 40 | |
| 7 | 2014 | 36 | |
| 8 | 2016 | 30 | |
| 9 | 2019 | 28 | |
| 10 | 2016 | 22 | |
| 11 | 2021 | 19 | |
| 12 | 2018 | 17 | |
| 13 | 2017 | 17 | |
| 14 | 2017 | 15 | |
| 15 | 2023 | 13 | |
| 16 | 2011 | 5 | |
| 17 | 2020 | 2 | |
| 18 | 2012 | 2 |
About András Vida
András Vida is a scholar working on Molecular Biology, Oncology, Immunology, Geriatrics and Gerontology and Microbiology, having authored 18 papers that have together received 628 indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (4 papers), Gut microbiota and health (3 papers), Sirtuins and Resveratrol in Medicine (3 papers), Bacterial Infections and Vaccines (2 papers), Antimicrobial Peptides and Activities (2 papers), Radiopharmaceutical Chemistry and Applications (2 papers), Immune cells in cancer (2 papers) and HER2/EGFR in Cancer Research (1 paper). The work is most often cited by research in Hepatology (61 citations), Geriatrics and Gerontology (24 citations), Oncology (177 citations), Immunology (121 citations) and Physiology (22 citations). András Vida has collaborated with scholars based in Hungary, United States and Netherlands. Frequent co-authors include Péter Bai, Edit Mikó, Judit Márton, Katalin Mikecz, Tibor T. Glant, Tündé Kovàcs, Borbála Kiss, Zoltán Szekanecz, Júlia Kurkó and Gyula Ujlaki. Their work appears in journals such as PLoS ONE, Journal of Pharmaceutical and Biomedical Analysis, Inflammation Research, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids and British Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.